Clinical Trial Update: Bexarotene in Preventing Breast Cancer in Women at Genetic Risk [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating bexarotene for breast cancer prevention in women at genetic risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Targretin (bexarotene)

Snippet

Sponsor: Baylor Breast Care Center | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED